Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
1.
Addiction ; 118(8): 1507-1516, 2023 08.
Artigo em Inglês | MEDLINE | ID: mdl-36898848

RESUMO

DESIGN: This was a prospective observational study. BACKGROUND AND AIMS: The characteristics of cannabis-involved motor vehicle collisions are poorly understood. This study of injured drivers identifies demographic and collision characteristics associated with high tetrahydrocannabinol (THC) concentrations. SETTING: The study was conducted in 15 Canadian trauma centres between January 2018 and December 2021. CASES: The cases (n = 6956) comprised injured drivers who required blood testing as part of routine trauma care. MEASUREMENTS: We quantified whole blood THC and blood alcohol concentration (BAC) and recorded driver sex, age and postal code, time of crash, crash type and injury severity. We defined three driver groups: high THC (THC ≥ 5 ng/ml and BAC = 0), high alcohol (BAC ≥ 0.08% and THC = 0) and THC/BAC-negative (THC = 0 = BAC). We used logistic regression techniques to identify factors associated with group membership. FINDINGS: Most injured drivers (70.2%) were THC/BAC-negative; 1274 (18.3%) had THC > 0, including 186 (2.7%) in the high THC group; 1161 (16.7%) had BAC > 0, including 606 (8.7%) in the high BAC group. Males and drivers aged less than 45 years had higher adjusted odds of being in the high THC group (versus the THC/BAC-negative group). Importantly, 4.6% of drivers aged less than 19 years had THC ≥ 5 ng/ml, and drivers aged less than 19 years had higher unadjusted odds of being in the high THC group than drivers aged 45-54 years. Males, drivers aged 19-44 years, rural drivers, seriously injured drivers and drivers injured in single-vehicle, night-time or weekend collisions had higher adjusted odds ratios (aORs) for being in the high alcohol group (versus THC/BAC-negative). Drivers aged less than 35 or more than 65 years and drivers involved in multi-vehicle, daytime or weekday collisions had higher adjusted odds for being in the high THC group (versus the high BAC group). CONCLUSIONS: In Canada, risk factors for cannabis-related motor vehicle collisions appear to differ from those for alcohol-related motor vehicle collisions. The collision factors associated with alcohol (single-vehicle, night-time, weekend, rural, serious injury) are not associated with cannabis-related collisions. Demographic factors (young drivers, male drivers) are associated with both alcohol and cannabis-related collisions, but are more strongly associated with cannabis-related collisions.


Assuntos
Acidentes de Trânsito , Consumo de Bebidas Alcoólicas , Dronabinol , Fumar Maconha , Ferimentos e Lesões , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Acidentes de Trânsito/estatística & dados numéricos , Fatores Etários , Consumo de Bebidas Alcoólicas/sangue , Dronabinol/sangue , Fumar Maconha/sangue , Medição de Risco , Fatores de Risco , Fatores Sexuais , Ferimentos e Lesões/epidemiologia
2.
J Thromb Haemost ; 2018 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-29883046

RESUMO

Essentials Nucleosomes and free DNA are two newly described biomarkers in venous thromboembolism (VTE). Reliability of nucleosomes, plasma free DNA and conventional hemostasis markers were studied. Hemostasis biological parameters vary over a short time-frame in VTE patients. Hemostasis biological parameters also vary over a short time-frame in healthy controls. SUMMARY: Background Previous studies have associated neutrophil-derived circulating nucleosomes and plasma free DNA with venous thromboembolism (VTE). However, there are few data concerning these two biomarkers and no studies have compared the reliability of nucleosomes and plasma free DNA against that of conventional hemostasis markers. Objectives We performed a 3-year prospective study of nucleosomes and plasma free DNA levels in comparison with conventional hemostatic biomarkers and blood cells. Patients/Methods Fifteen healthy controls and 22 randomly selected patients with a history of VTE were followed monthly for 6 months. The reliability of these markers was evaluated by the intraclass correlation coefficient (ICCs). Results and Conclusions In healthy controls and patients, we found a low reliability for nucleosomes and plasma free DNA, with ICCs at 0.538 (95% confidence interval [CI], 0.334-0.764) and 0.091 (95% CI, -0.026-0.328), respectively, in the healthy controls, and at 0.213 (95% CI, 0.042-0.463) and 0.161 (CI 95%, 0.008-0.398) in the patient group. For the conventional hemostasis biomarkers and for blood cells, reliability ranged from poor to good in the healthy volunteers and from poor to acceptable in the patient group. Our study shows for the first time that hemostasis biological parameters spontaneously vary over a short time-frame in VTE patients and, more surprisingly, in normal individuals. The clinical value of such intra-individual variations is currently unknown. This variability might mean reinterpreting diagnostic or prognostic models based on static evaluation of individuals. Studying the intrinsic value of individual patterns of markers' variability is warranted.

3.
Br J Anaesth ; 119(2): 239-248, 2017 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-28854537

RESUMO

OBJECTIVE: To investigate the prognostic significance of central venous-to-arterial carbon dioxide difference (cv-art CO 2 gap) during septic shock in patients with and without impaired cardiac function. METHODS: We performed a prospective cohort study in 10 French intensive care units. Patients suffering from septic shock were assigned to the impaired cardiac function group ('cardiac group', n =123) if they had atrial fibrillation (AF) and/or left ventricular ejection fraction (LVEF) <50% at study entry and to the non-cardiac group ( n =240) otherwise. RESULTS: Central venous and arterial blood gases were sampled every 6 h during the first 24 h to calculate cv-art CO 2 gap. Patients in the cardiac group had a higher cv-art CO 2 gap [at study entry and 6 and 12 h (all P <0.02)] than the non-cardiac group. Patients in the cardiac group with a cv-art CO 2 gap >0.9 kPa at 12 h had a higher risk of day 28 mortality (hazard ratio=3.18; P =0.0049). Among the 59 patients in the cardiac group with mean arterial pressure (MAP) ≥65 mm Hg, central venous pressure (CVP) ≥8 mm Hg and central venous oxygen saturation (ScvO 2 ) ≥70% at 12 h, those with a high cv-art CO 2 gap (>0.9 kPa; n =19) had a higher day 28 mortality (37% vs. 13%; P =0.042). In the non-cardiac group, a high cv-art CO 2 gap was not linked to a higher risk of day 28 death, whatever the threshold value of the cv-art CO 2 gap. CONCLUSION: Patients with septic shock and with AF and/or low LVEF were more prone to a persistent high cv-art CO 2 gap, even when initial resuscitation succeeded in normalizing MAP, CVP, and ScvO 2 . In these patients, a persistent high cv-art CO 2 gap at 12 h was significantly associated with higher day 28 mortality.


Assuntos
Dióxido de Carbono/sangue , Choque Séptico/sangue , Choque Séptico/mortalidade , Adolescente , Adulto , Idoso , Pressão Arterial , Pressão Venosa Central , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prognóstico , Estudos Prospectivos , Choque Séptico/fisiopatologia , Função Ventricular Esquerda , Adulto Jovem
4.
Opt Lett ; 41(20): 4637-4640, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-28005855

RESUMO

We demonstrate numerically that a semiconductor laser subjected to phase-conjugate feedback (PCF) can exhibit an enhancement in the complexity of chaos by comparison to conventional optical feedback. Using quantifiers from spectral analysis and information theory, we demonstrate that under similar parametric conditions, PCF exhibits a larger chaotic bandwidth and higher spectral flatness and statistical complexity. These properties are of utmost importance for applications in secure communications and random number generation.

5.
Opt Express ; 22(14): 17271-80, 2014 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-25090541

RESUMO

We demonstrate the physical generation of random bits at high bit rates (> 100 Gb/s) using optical chaos from a solitary laser diode and therefore without the complex addition of either external optical feedback or injection. This striking result is obtained despite the low dimension and relatively small bandwidth of the laser chaos, i.e. two characteristics that have been so far considered as limiting the performances of optical chaos-based applications. We unambiguously attribute the successful randomness at high speed to the physics of the laser chaotic polarization dynamics and the resulting growth rate of the dynamical entropy.

6.
Eur J Clin Microbiol Infect Dis ; 33(10): 1861-7, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24859907

RESUMO

The fully human anti-lipopolysaccharide (LPS) immunoglobulin M (IgM) monoclonal antibody panobacumab was developed as an adjunctive immunotherapy for the treatment of O11 serotype Pseudomonas aeruginosa infections. We evaluated the potential clinical efficacy of panobacumab in the treatment of nosocomial pneumonia. We performed a post-hoc analysis of a multicenter phase IIa trial (NCT00851435) designed to prospectively evaluate the safety and pharmacokinetics of panobacumab. Patients treated with panobacumab (n = 17), including 13 patients receiving the full treatment (three doses of 1.2 mg/kg), were compared to 14 patients who did not receive the antibody. Overall, the 17 patients receiving panobacumab were more ill. They were an average of 72 years old [interquartile range (IQR): 64-79] versus an average of 50 years old (IQR: 30-73) (p = 0.024) and had Acute Physiology and Chronic Health Evaluation II (APACHE II) scores of 17 (IQR: 16-22) versus 15 (IQR: 10-19) (p = 0.043). Adjunctive immunotherapy resulted in an improved clinical outcome in the group receiving the full three-course panobacumab treatment, with a resolution rate of 85 % (11/13) versus 64 % (9/14) (p = 0.048). The Kaplan-Meier survival curve showed a statistically significantly shorter time to clinical resolution in this group of patients (8.0 [IQR: 7.0-11.5] versus 18.5 [IQR: 8-30] days in those who did not receive the antibody; p = 0.004). Panobacumab adjunctive immunotherapy may improve clinical outcome in a shorter time if patients receive the full treatment (three doses). These preliminary results suggest that passive immunotherapy targeting LPS may be a complementary strategy for the treatment of nosocomial O11 P. aeruginosa pneumonia.


Assuntos
Anticorpos Antibacterianos/administração & dosagem , Anticorpos Monoclonais/administração & dosagem , Fatores Imunológicos/administração & dosagem , Imunoterapia/métodos , Pneumonia Bacteriana/terapia , Pseudomonas aeruginosa/imunologia , Adulto , Idoso , Anticorpos Antibacterianos/efeitos adversos , Anticorpos Monoclonais/efeitos adversos , Anticorpos Monoclonais/farmacocinética , Infecção Hospitalar/microbiologia , Infecção Hospitalar/terapia , Feminino , Humanos , Imunoglobulina M/administração & dosagem , Imunoglobulina M/efeitos adversos , Fatores Imunológicos/efeitos adversos , Fatores Imunológicos/farmacocinética , Masculino , Pessoa de Meia-Idade , Pneumonia Bacteriana/microbiologia , Estudos Prospectivos , Pseudomonas aeruginosa/classificação , Sorogrupo , Resultado do Tratamento
7.
Opt Express ; 22(6): 6772-7, 2014 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-24664025

RESUMO

We report experimentally a bistability between two limit cycles (i.e. time-periodic dynamics) in a free-running vertical-cavity surface-emitting laser. The two limit cycles originate from a bifurcation on two elliptically polarized states which exhibit a small frequency difference and whose main axes are symmetrical with respect to the linear polarization eigenaxes at threshold. We demonstrate theoretically that this peculiar behavior can be explained in the framework of the spin-flip model model by taking into account a small misalignment between the phase and amplitude anisotropies.

8.
Heart Lung ; 43(2): 120-3, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24360614

RESUMO

Lenalidomide is an immunomodulating drug structurally similar to thalidomide. It is indicated for patients with relapsing or refractory multiple myeloma in combination with dexamethasone, and for patients with myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality. It is also used to treat other myelodysplastic syndromes such as myelofibrosis and lymphoma. We report a case of organizing pneumonia leading to acute respiratory distress syndrome (ARDS) after long-term administration of lenalidomide, along with a review of the literature.


Assuntos
Fatores Imunológicos/efeitos adversos , Síndrome do Desconforto Respiratório/induzido quimicamente , Talidomida/análogos & derivados , Humanos , Lenalidomida , Pulmão/diagnóstico por imagem , Masculino , Pessoa de Meia-Idade , Mielofibrose Primária/tratamento farmacológico , Síndrome do Desconforto Respiratório/diagnóstico por imagem , Talidomida/efeitos adversos , Tomografia Computadorizada por Raios X
9.
Neurocrit Care ; 18(3): 386-90, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23532708

RESUMO

BACKGROUND: Since the first description of Hashimoto's Encephalitis (HE) in 1966 by Lord Brain, the number of reported cases has continued to increase. In addition, cases of status epilepticus have been reported, suggesting a role for intensive care unit (ICU) practitioners in taking care of patients with HE. METHODS: A retrospective cohort study in ICU patients with HE was performed at the University Hospital of Tours, France. RESULTS: Eight HE cases were admitted to the ICU between 1/1/2000 and 1/1/2012. Herein, we describe the characteristics of the patients, with an emphasis on ICU disease management and its outcome. CONCLUSION: ICU practitioners should be aware of this disease, since it can include life-threatening presentations.


Assuntos
Encefalopatias/diagnóstico , Cuidados Críticos/métodos , Doença de Hashimoto/diagnóstico , Estado Epiléptico/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Encefalopatias/complicações , Encefalopatias/terapia , Estudos de Coortes , Encefalite , Feminino , Doença de Hashimoto/complicações , Doença de Hashimoto/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Estado Epiléptico/etiologia
10.
J Small Anim Pract ; 54(4): 179-83, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23496099

RESUMO

OBJECTIVES: To evaluate the possible role of Alternaria and Cladosporium species in the pathogenesis of canine lymphoplasmacytic rhinitis by comparing the amount of specific fungal DNA in nasal mucosal biopsies between dogs without nasal neoplasia and those with lymphoplasmacytic rhinitis or nasal neoplasia. METHODS: Quantitative real-time polymerase chain reaction (qPCR) assays detecting DNA from Alternaria and Cladosporium fungi were applied to nasal mucosal biopsies collected from dogs with lymphoplasmacytic rhinitis (n = 8), dogs with nasal neoplasia (n = 10) and control animals (n = 10). A copy number for each sample was calculated using a standard curve of known copy number and differences amongst groups were assessed using Kruskal-Wallis tests. RESULTS: No significant difference was found between the groups. Low levels of Alternaria DNA (10-100 copies/PCR) were detected in one sample; very low levels of DNA (<10 copies/qPCR) were detected in 6 samples, and 21 samples were negative. Low levels of Cladosporium DNA were detected in 2 samples; very low levels of DNA in 18; and 8 were negative. CLINICAL SIGNIFICANCE: Results of this study reveal that Alternaria and Cladosporium species are part of the canine nasal flora, and that these fungi are probably not involved in the pathogenesis of lymphoplasmacytic rhinitis.


Assuntos
Alternaria/isolamento & purificação , Cladosporium/isolamento & purificação , Doenças do Cão/microbiologia , Nariz/microbiologia , Rinite/veterinária , Alternaria/patogenicidade , Animais , Cladosporium/patogenicidade , DNA Fúngico/análise , Cães , Feminino , Masculino , Neoplasias Nasais/veterinária , Reação em Cadeia da Polimerase/veterinária , Rinite/microbiologia
11.
Ann Fr Anesth Reanim ; 31(5): e67-72, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22464162

RESUMO

OBJECTIVE: The passive leg raising maneuver (PLR) for fluid responsiveness testing relies on cardiac output (CO) measurements or invasive measurements of arterial pressure (AP) whereas the initial hemodynamic management during shock is often based solely on brachial cuff measurements. We assessed PLR-induced changes in noninvasive oscillometric readings to predict fluid responsiveness. STUDY DESIGN: Multicentre interventional study. PATIENTS AND METHODS: In ICU sedated patients with circulatory failure, AP (invasive and noninvasive readings) and CO measurements were performed before, during PLR (trunk supine, not modified) and after 500-mL volume expansion. Areas under the ROC curves (AUC) were determined for fluid responsiveness (>10% volume expansion-induced increase in CO) prediction. RESULTS: In 112 patients (19% with arrhythmia), changes in noninvasive systolic AP during PLR (noninvasiveΔ(PLR)SAP) only predicted fluid responsiveness (cutoff 17%, n=21, positive likelihood ratio [LR] of 26 [18-38]), not unresponsiveness. If PLR-induced change in central venous pressure (CVP) was at least of 2 mm Hg (n=60), suggesting that PLR succeeded in altering cardiac preload, noninvasiveΔ(PLR)SAP performance was good: AUC of 0.94 [0.85-0.98], positive and negative LRs of 5.7 [4.6-6.8] and 0.07 [0.009-0.5], respectively, for a cutoff of 9%. Of note, invasive AP-derived indices did not outperform noninvasiveΔ(PLR)SAP. CONCLUSION: Regardless of CVP (i.e., during "blind PLR"), noninvasiveΔ(PLR)SAP more than 17% reliably identified fluid responders. During "CVP-guided PLR", in case of sufficient change in CVP, noninvasiveΔ(PLR)SAP performed better (cutoff of 9%). These findings, in sedated patients who had already undergone volume expansion and/or catecholamines, have to be verified during the early phase of circulatory failure (before an arterial line and/or a CO measuring device is placed).


Assuntos
Determinação da Pressão Arterial/métodos , Pressão Sanguínea/fisiologia , Hidratação/métodos , Perna (Membro)/fisiologia , Idoso , Área Sob a Curva , Arritmias Cardíacas/complicações , Arritmias Cardíacas/terapia , Débito Cardíaco/fisiologia , Pressão Venosa Central/fisiologia , Cuidados Críticos , Feminino , Hemodinâmica/fisiologia , Humanos , Perna (Membro)/irrigação sanguínea , Masculino , Pessoa de Meia-Idade , Postura/fisiologia , Valor Preditivo dos Testes , Curva ROC , Fluxo Sanguíneo Regional/fisiologia , Choque/diagnóstico , Choque/terapia
13.
Vet Immunol Immunopathol ; 145(3-4): 618-24, 2012 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-22321737

RESUMO

The pathogenesis of canine sino-nasal aspergillosis (SNA) and lymphoplasmacytic rhinitis (LPR) remains poorly understood. The innate immune system is implicated in the etiology of human chronic rhinosinusitis. Therefore, we hypothesized that dysfunction in innate immunity could be implicated in the pathogenesis of SNA and LPR. Expression of messenger RNA (mRNA) encoding Toll-like receptors (TLRs) 1-10 and NOD-like receptors (NODs) 1 and 2 in nasal mucosal biopsies from SNA or LPR dogs was compared with mucosa from healthy controls. Gene expression was quantified using quantitative real-time reverse transcriptase polymerase chain reaction normalized against multiple housekeeper genes. All TLR and NOD genes were quantified in all samples. SNA was associated with significantly increased expression of TLRs 1-4, 6-10; and NOD2, relative to controls. LPR was associated with significantly increased expression of TLRs 1, 2, 6-8, relative to controls. There was significantly more expression of TLRs 1, 4, 6-10 and NOD2 in SNA dogs than in LPR dogs. The significance of these differences in the pathogenesis of these diseases is yet to be determined.


Assuntos
Aspergilose/veterinária , Doenças do Cão/imunologia , Mucosa Nasal/imunologia , Proteína Adaptadora de Sinalização NOD1/genética , Proteína Adaptadora de Sinalização NOD2/genética , RNA Mensageiro/análise , Rinite/veterinária , Receptores Toll-Like/genética , Animais , Aspergilose/imunologia , Cães , Regulação da Expressão Gênica , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Rinite/imunologia
16.
Vet J ; 187(2): 225-8, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20064732

RESUMO

The aims of this study were to evaluate the effect of age on bronchoscopic features and bronchoalveolar lavage fluid (BALF) cellularity in dogs. Thirty healthy beagle dogs from three age groups were included: young dogs (10 months to 4.5 years of age; n=8), middle-aged dogs (5-8 years old; n=13) and older dogs (>8 years; n=9). Haematology, thoracic radiography, bronchoscopy and bronchoalveolar lavage were performed; bronchoscopic findings were scored and BALF total and differential cell counts were determined. The total bronchoscopic score was higher in older dogs; these dogs had more irregular bronchial mucosa, more prominent mucosal vessels and bronchiectasis. Younger dogs had a higher percentage of neutrophils in BALF compared with middle-aged and old dogs and a higher percentage of lymphocytes in BALF compared with middle-aged dogs. The results show that age has an effect on bronchoscopic features of airways and the composition of BALF in the dog.


Assuntos
Líquido da Lavagem Broncoalveolar/citologia , Broncoscopia/veterinária , Cães/fisiologia , Fatores Etários , Animais , Contagem de Células/veterinária , Estudos Transversais , Feminino , Contagem de Linfócitos/veterinária , Masculino , Neutrófilos
17.
J Thromb Haemost ; 8(4): 707-13, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20141580

RESUMO

BACKGROUND: Half of all venous thromboembolism (VTE) cases during pregnancy are associated with a maternal thrombophilia. The influence of paternal genotype on the placenta and in the genesis of VTE has not been described. OBJECTIVES: To determine if the maternal and paternal Ser219Gly dimorphism of the endothelial protein C receptor (EPCR), evaluated through detection of the PROCR 6936G allele, is a risk factor for VTE during pregnancy. METHODS: Using a case-control study nested in the NOHA first cohort of primigravidae, 66 patient couples with a first episode of gestational VTE and randomly selected non-thrombotic control couples were investigated. For each couple, factor V gene (F5) G1691A, factor II gene (F2) G20210A, factor XII gene (F12) C46T and PROCR A6936G polymorphisms were determined. RESULTS: Only maternal F5 1691A, F2 20210A and F12 46T alleles were independently associated with iliac and infra-iliac deep vein thromboses (DVT). The maternal PROCR 6936G allele was a mild risk factor for iliac DVT (OR = 5.5 [2.3-13.0]). The paternal PROCR 6936G allele was also a mild independent risk factor for iliac DVT (OR = 2.6 [1.1-6.2]) and only during pregnancy (rather than postpartum) among maternal carriers of the F5 1691A allele (OR = 77.6 [4.2 to > 999.9]). CONCLUSIONS: The paternal PROCR 6936G allele could be a risk factor for maternal iliac DVT. Its impact was milder than the F5 1691A and F2 20210A polymorphisms in mothers. We hypothesize that the prothrombotic effect of the paternal PROCR 6936G allele is localized. Therefore, DVT during pregnancy may be influenced by trophoblastic cell-surface proteins inherited from both maternal and paternal alleles.


Assuntos
Antígenos CD/genética , Veia Ilíaca , Polimorfismo Genético , Complicações Hematológicas na Gravidez/genética , Receptores de Superfície Celular/genética , Trombose Venosa/genética , Adulto , Estudos de Casos e Controles , Distribuição de Qui-Quadrado , Receptor de Proteína C Endotelial , Fator V/genética , Fator XII/genética , Pai , Feminino , França , Frequência do Gene , Predisposição Genética para Doença , Humanos , Modelos Logísticos , Mães , Razão de Chances , Linhagem , Fenótipo , Gravidez , Protrombina/genética , Medição de Risco , Fatores de Risco , Adulto Jovem
19.
J Thromb Haemost ; 6(12): 2067-74, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18826390

RESUMO

BACKGROUND: Severe postpartum hemorrhages (PPH) represent a significant cause of maternal morbidity/mortality, but little is known about its hemostasis-related risk factors. Among the 32 463 women enrolled in the NOHA First cohort, 317 developed severe PPH (S-PPH group), 1269 non-severe PPH (NS-PPH group) and the remaining individuals were considered as control women (C group). METHODS: We performed a case-control study, including 317 triplets of women allocated from the three groups that shared the same clinical characteristics as the S-PPH group. RESULTS: From values obtained 6-9 months after delivery, low (but not-deficient) levels of fibrinogen, von Willebrand factor (VWF) antigen, factor (F) XI, platelet CD42b, TRAP-induced increase of platelet CD41a and high values of serum residual prothrombin activity or closure aperture times using the collagen-ADP cartridge on the PFA-100 system, and blood group O, were independently associated with a significant risk of severe PPH. Being positive for at least two of these eight variables was found in 1.6%, 3.5% and 20.8% of the women from the C, the NS-PPH and the S-PPH groups, respectively, the odds ratio for S-PPH in such a case being 16.4, 95%CI (6.5-41), P < 0.0001. CONCLUSIONS: Women with some hemostasis-related variables at the low or high end of the population distributions are prone to the severe forms of PPH. Clinical trials will allow us to know if acting on these risk factors can lower the clinical severity of PPH.


Assuntos
Hemostasia , Hemorragia Pós-Parto/etiologia , Sistema ABO de Grupos Sanguíneos , Adulto , Biomarcadores/sangue , Testes de Coagulação Sanguínea , Estudos de Casos e Controles , Feminino , Humanos , Hemorragia Pós-Parto/diagnóstico , Gravidez , Fatores de Risco , Índice de Gravidade de Doença , Distribuições Estatísticas , Adulto Jovem
20.
Rev Mal Respir ; 25(6): 731-41, 2008 Jun.
Artigo em Francês | MEDLINE | ID: mdl-18772830

RESUMO

Inhaled therapy is routinely employed during mechanical ventilation. Several factors affect aerosol delivery: the aerosol device, particle size, ventilator parameters, ventilator circuit and hygrometry. Non invasive ventilation is commonly used for treatment of exacerbations of chronic obstructive pulmonary disease. However, there are few data concerning the factors affecting aerosol delivery during this mode of ventilation. Optimal aerosol delivery during mechanical ventilation depends on the aerosol device, the respirator circuit and settings, and the patient himself.


Assuntos
Aerossóis , Nebulizadores e Vaporizadores , Respiração Artificial , Aerossóis/administração & dosagem , Hélio , Humanos , Nebulizadores e Vaporizadores/estatística & dados numéricos , Tamanho da Partícula , Preparações Farmacêuticas/administração & dosagem , Doença Pulmonar Obstrutiva Crônica/terapia , Respiração Artificial/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...